NCT06423690View on ClinicalTrials.gov

First in Human Study for the Assessment of Safety and Initial Performance of the EAS1 System

NARecruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

May 15, 2025

Study Completion Date

July 15, 2025

Conditions
Lung Cancer
Interventions
DEVICE

EAS1 System

tumor ablation system in IRE method

Trial Locations (3)

Unknown

RECRUITING

Meir Medical Center, Kfar Saba

RECRUITING

University Hospital Complex of Salamanca, Salamanca

RECRUITING

Royal Brompton Hospital, London

All Listed Sponsors
lead

Snipe Medical

INDUSTRY